Surgical Pathology Criteria

Clear Cell Tubulopapillary Renal Cell Carcinoma

Supplemental Studies

Immunohistology

CK7, EMA, carbonic anhydrase IX (CA9) 100% strong pos
CD10 neg to focal (<10% of cells)
AMACR/racemase/P504S neg
TFE3

neg

Genetic Studies

Stanford Medicine Resources:

Footer Links: